B-67/100

Is C.H. Robinson (CHRW) a risky stock?

Sector: Industrials Price: $208.88 Composite: 67/100

As of July 21, 2026, Clavix grades C.H. Robinson (CHRW) B- for risk, a composite score of 67 out of 100 on an A+ to F scale, which puts CHRW in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind CHRW's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how CHRW scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
61
News sentimentscored, sourced recent coverage
52
Macro exposuresensitivity to rates, dollar, oil
65
Sector resiliencestrength vs the broad market
71
Price stabilitydrawdown and volatility
50

What's moving CHRW's risk right now

Company-specific signals Clavix flags behind CHRW's current grade, drawn from recent news and filings as of July 21, 2026.

Regulatory · raising risk

C.H. Robinson faces scrutiny for not using AI to vet the trucking carriers it works with, which could expose it to lawsuits or fines. Critics say applying AI everywhere except this area leaves the company open to legal and reputational problems.

Valuation · raising risk

A bearish analysis argues CHRW's recent stock gains aren't backed by strong business fundamentals. The piece highlights structural risks that could limit future returns for investors buying at today's prices.

Valuation · supporting the grade

Truist lifted its price target on C.H. Robinson to $215, signaling continued rating confidence in the stock's upside. The upward revision reflects a positive view on the company's valuation from current levels.

What a B- grade means

On the Clavix A+ to F scale, CHRW's composite of 67 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell CHRW or any security. Grades are risk indicators, not predictions of return. Data may be delayed.